Divergent relationships among soluble tumor necrosis factor-α receptors 1 and 2, insulin resistance, and endothelial function [7]

Diabetes Care

Volumn 29, Issue 6, 2006, Pages 1460-1461

  Esteve, Eduardo ^a   Castro, Antoni ^a   López Bermejo, Abel ^a   Vendrell, Joan ^b   Ricart, Wifredo ^a   Fernández Real, Jose Manuel ^a  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

BODY MASS; BRACHIAL ARTERY; CELL FUNCTION; CELL GROWTH; CELL SURFACE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME IMMUNOASSAY; GLUCOSE TOLERANCE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LETTER; MALE; MOUSE; NONHUMAN; SMOKING; SPAIN; SYSTOLIC BLOOD PRESSURE; TUMOR NECROSIS; UPREGULATION; VASODILATATION;

ENDOTHELIUM, VASCULAR; GLUCOSE INTOLERANCE; HUMANS; INSULIN RESISTANCE; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; REFERENCE VALUES; VASODILATION;

EID: 33746463577     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-0423     Document Type: Letter

References (9)

1. Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685-1695, 2005
2. Fernández-Real JM, Ricart W: Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 24:278-301, 2003
3. Chia S, Qadan M, Newton R, Ludlam C, Fox KA, Newby DE: Intra-arterial tumor necrosis factor-α impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans. Arterioscler Thromb Vasc Biol 23:695-701, 2003
4. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D: Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 175:323-329, 1992
5. Fernandez-Real JM, Lainez B, Vendrell J, Rigla M, Castro A, Peñarroja G, Broch M, Perez A, Richart C, Engel P, Ricart W: Shedding of TNF-alpha receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 282:952-959, 2002
6. Selinsky CL, Boroughs KL, Halsey WA, Howel MD: Multifaceted inhibition of anti-tumor immune mechanisms by soluble tumor necrosis factor receptor type I. Inmunology 94:88-93, 1998
7. Sugano M, Hata T, Tsuchida K, Suematsu N, Oyama J, Satoh S, Makino N: Local delivery of soluble TNF-alpha receptor 1 gene reduces infarct size following ischemia/reperfusion injury in rats. Mol Cell Biochem 266:127-132, 2004
8. Benjafield AV, Wang XL, Morris BJ: Tumor necrosis factor receptor 2 gene (TNFRSF1b) in genetic basis of coronary artery disease. J Mol Med 79:109-115, 2001
9. Douni E, Kollias G: A critical role of the p75 tumor necrosis factor receptor (p75TNFR) in organ inflammation independent of TNF, lymphotoxin α, or the p55TNFR. J Exp Med 188:1343-1352, 1998